📊 Score Breakdown
Offering Ability
40
Cash Runway
65
Float Risk
40
Warrant Exposure
40
Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
24%
📜 Warrant Exercise
35%
• Massive warrant overhang: 799418100% of shares outstanding
💰 Capital Raise
15%
• Under 12 months cash (7mo)
📉 Score Deterioration
10%
• Score in HIGH risk zone (63/100)
💹 Market Data
Market CapN/A
Shares OutstandingN/A
Float808.7K
Cash$1.64M
Debt$5.66M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest11.6K
Days to Cover2.4
% of Float1.4%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NEXRW
📊 NEXRW FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NEXRW Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.